Journal of the Neurological Sciences
Volume 290, Issue 1 , Pages 52-56 , 15 March 2010

Compulsive habits in restless legs syndrome patients under dopaminergic treatment

  • Emmanuelle Pourcher

      Affiliations

    • Quebec Memory and Motor Skills Disorders Research Center, Clinique Sainte-Anne, Québec, Québec, Canada
    • Psychology and Cognitive Neuroscience Laboratory, Université Paris Descartes–CNRS (UMR-8189), Boulogne-Billancourt, France
    • Centre de Recherche Université Laval Robert-Giffard, Beauport, Québec, Canada
    • Corresponding Author InformationCorresponding author. Quebec Memory and Motor Skills Disorders Research Center, Clinique Sainte-Anne, 65, rue Sainte-Anne, Québec, Québec, Canada G1R 3X5. Tel.: +1 418 692 2227; fax: +1 418 692 3338.
    • ,
  • Sophie Rémillard

      Affiliations

    • Quebec Memory and Motor Skills Disorders Research Center, Clinique Sainte-Anne, Québec, Québec, Canada
    • ,
  • Henri Cohen

      Affiliations

    • Quebec Memory and Motor Skills Disorders Research Center, Clinique Sainte-Anne, Québec, Québec, Canada
    • Psychology and Cognitive Neuroscience Laboratory, Université Paris Descartes–CNRS (UMR-8189), Boulogne-Billancourt, France

Received 5 October 2009 ,Accepted 23 November 2009.

References 

  1. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord. 1995;10:634–642
  2. Garcia-Borreguero D, Odin P, Schwarz C. Restless legs syndrome: an overview of the current understanding and management. Acta Neurol Scand. 2004;109:303–317
  3. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5:237–246
  4. Wetter TC, Eisensehr I, Trenkwalder C. Functional neuroimaging studies in restless legs syndrome. Sleep Med. 2004;5:401–406
  5. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol. 2005;4:465–475
  6. Voon V. Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease. Mov Disord. 2004;19:367–370
  7. Friedman JH. Punding on levodopa. Biol Psychiatry. 1994;36:350–351
  8. Fernandez HH, Friedman JH. Punding on L-dopa. Mov Disord. 1999;14:836–838
  9. Molina JA, Sainz-Artiga MJ, Fraile A, Jiménez-Jiménez FJ, Villanueva C, Orti-Pareja M, et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?. Mov Disord. 2000;15:869–872
  10. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology. 2003;61:422–423
  11. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord. 2006;21:524–529
  12. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006;63:969–973
  13. Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, et al. Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord. 2008;23:75–80
  14. Voon V, Hassan K, Zurowski M, Duff-Canning S, de Souza M, Fox S, et al. Prospective prevalence of pathologic gambling and medication association in Parkinson's disease. Neurology. 2006;66:1750–1752
  15. Voon V, Thomsen T, Miyasaki M, de Souza M, Shafro A, Fox SH, et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol. 2007;64:212–216
  16. Klos KJ, Bowers JH, Josephs KA, Matsumoto JY, Ahlskog JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2005;11:381–386
  17. Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology. 2006;67:1258–1261
  18. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology. 2006;67:1254–1257
  19. Quickfall J, Suchowersky O. Pathological gambling associated with dopamine agonist use in restless legs syndrome. Parkinsonism Relat Disord. 2007;13:535–536
  20. Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology. 2007;68:301–303
  21. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–132
  22. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory - II. San Antonio, TX: Psychological Corporation; 1996;
  23. Hays RD, Stewart AL. Sleep measures. In:  Alsje E editors. Measuring functioning and well-being: The Medical Outcomes Study approach. Durham, NC: Duke University Press; 1992;p. 235–259
  24. Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med. 2005;6:41–44
  25. Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord. 2004;19:397–405
  26. Diagnostic and Statistical Manual of Mental Disorders. In: 4th ed. Washington: American Psychiatric Association; 1994;
  27. SPSS I., SPSS graduate pack for Mac OS X, Version 17, 2008, Chicago, Illinois.
  28. Ritz F, Lesperance P, Panisset M. Addictive behaviours in RLS patients on dopaminergic agonists. Mov Disord. 2006;21–15:S 662–S 663
  29. Okuji Y, Matsuura M, Kawasaki N, Kometani S, Shimoyama T, Sato M, et al. Prevalence of insomnia in various psychiatric diagnostic categories. Psychiatry Clin Neurosci. 2002;56:239–240
  30. Uhde TW. Anxiety disorders. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and practice of sleep medicine. Saunders WB Company; 2000;p. 1123–1139
  31. Benca RM. Mood disorders. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and practice of sleep medicine. Saunders WB Company; 2000;p. 1140–1157
  32. Claghorn JL, Mathew RJ, Weinman ML, Hruska N. Daytime sleepiness in depression. J Clin Psychiatry. 1981;42:342–343
  33. Walter P, Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol. 2006;5:878–886

PII: S0022-510X(09)00973-3

doi: 10.1016/j.jns.2009.11.010

Journal of the Neurological Sciences
Volume 290, Issue 1 , Pages 52-56 , 15 March 2010

Article Tools